Crossmark

Early-life fingolimod treatment improves intestinal homeostasis and pancreatic immune tolerance in non-obese diabetic mice

Published Online: 2021-01-20

Published Print: 2021-10

Authors

Jia, Ling-ling

Zhang, Ming

Liu, He

Sun, Jia

Pan, Li-long
License Information

Text and Data Mining valid from 2021-01-20

Version of Record valid from 2021-01-20
More Information

Article History

Received: 11 April 2020

Accepted: 26 September 2020

First Online: 20 January 2021

Competing interests

: The authors declare no competing interests.

Document is current